TM

Tapan Maniar

Founder of Aiolos Bio

Cambridge, Massachusetts

Overview 

Tapan Maniar is the Chief Business Officer at Aiolos Bio, having previously held roles at Bain Capital Life Sciences and Genentech BD. With a Ph.D. from The Rockefeller University and experience as a Principal at Bain Capital, Maniar's career highlights include leading business development efforts at Genentech and co-founding Aiolos Bio.

Work Experience 

AB

Aiolos Bio

  • Chief Business Officer & Co-Founder

    2023 - Current

Aiolos Bio is a biotech company developing innovative therapies for respiratory diseases and immune conditions.

Raised $245,000,000.00 from Forbion Capital Partners, Atlas Venture, Sofinnova Investments, RA Capital Management and Bain Capital Life Sciences.

aiolosbio.com
EB

Emalex Biosciences

  • Board Observer

    2022 - 2023

Emalex Biosciences is a biotech startup that develops new treatments for central nervous system disorders.

Raised $300,000,000.00 from Paragon Biosciences, Fidelity, Valor Equity Partners and Bain Capital Life Sciences.

emalexbiosciences.com
RP

Rivus Pharmaceuticals

  • Board Observer

    2022 - 2023

Rivus Pharmaceuticals operates as a biopharmaceutical company dedicated to improving cardio-metabolic health.

Raised $167,000,000.00 from RxCapital, BB Biotech Ventures, Medicxi, Bain Capital Life Sciences, RA Capital Management and Longitude Capital.

rivuspharma.com
BC

Bain Capital

  • Principal

    2021 - 2023

Bain Capital is an alternative investment firm specializing in private equity, venture capital, and credit products.

baincapital.com
G

Genentech

  • Genentech Head of BD for Tech Platforms | Pharma Partnering

    2017 - 2021

    Led Genentech's BD efforts to access research technology platforms and novel modalities across therapeutic areas. Executed numerous discovery/pre-clinical stage collaborations, clinical-stage partnerships, and an M&A. Notable transactions include: Heptares (GPCR targeting), Scenic Biotech (Genetic Modifiers), X-Chem (DEL for Oncology), Skyhawk Tx (SM RNA splicing), Ribometrix (RNA modulation), Genesis Tx (ML for small molecules) and Prescient Design (ML for large molecules).

Genentech specializes in genetic testing and personalized medicine.

gene.com
M&

McKinsey & Company

  • Engagement Manager

    2015 - 2017

  • Associate

    2013 - 2014

McKinsey Growth Tech serves leading growth stage tech players, venture capital, and growth private equity

mckinsey.com

Rockefeller University / Howard Hughes Medical Institute

  • Postdoctoral Associate

    2011 - 2012

TR

The Rockefeller University

  • Graduate Student

    2004 - 2011

RU

Rockefeller University

  • Summer Research Assistant (SURF Program)

    2003 - 2003

BC

Bard College

  • Research Assistant (ISROP Program)

    2001 - 2003

Education 

Articles About Tapan

Relevant Websites